KIMS Sets Floor Price at ₹771.73 for Equity Share Placement under QIP
Krishna Institute of Medical Sciences Limited (KIMS) has approved the floor price for its Qualified Institutions Placement (QIP) of equity shares, following the consideration by its Finance and Investment Committee on June 16, 2026.The Company had earlier received approval from its Board of Directors on March 11, 2026, and shareholders granted a special resolution via postal ballot on April 15, 2026, for the Issue of equity shares with a face value of ₹2 each. The Finance and Investment Committee approved several key aspects related to the placement during its meeting held on June 16, 2026.
The committee adopted the preliminary placement document and authorized the opening of the Issue. As part of these approvals, KIMS set the floor price for the equity shares at ₹771.73 per Equity Share.
The Finance and Investment Committee also fixed the Relevant Date for the Issue as June 16, 2026. The Company holds the option to offer a discount of up to 5% on this calculated floor price during the Issue, with the final determination of the issue price remaining dependent on consultation with the appointed book running lead managers.
A critical next step involves the Finance and Investment Committee meeting scheduled for June 19, 2026. This meeting is set to consider and approve the final issue price of the Equity Shares, which includes any permissible discount based on the previously approved structure.
Trading in KIMS' securities has been restricted from June 16, 2026, until 48 hours after the determination of the final issue price for all Designated Persons as per the Company's Prevention of Insider Trading Code of Conduct.
KIMS Stock Price Movement
KIMS shares settled higher today, finishing at ₹778.65 after gaining 1.31%, driven by strong momentum in the Healthcare sector. The stock traded robustly throughout the session, with a total volume of 551,283 shares recorded.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.